Who We Are
The opioid epidemic is only expected to worsen over the next 5 years.
We intend to change that.
We reduce harm, celebrate milestones, and offer unconditional support.
Our company was designed to align its success with that of our patients, providers and partners. If ever there’s doubt, patients come first.
The more we grow, the more people are counting on us. We take this responsibility very seriously.
We’re grateful to customers and investors for recognizing that when we do the right thing for patients, ultimately, everyone will win.
Our program is not only evidence-based, it's evidence-led. The industry has been plagued by harmful misinformation for too long.
Plans are built on science, guided by decades of real experience, and improved continuously by technology.
True human connection is necessary to drive meaningful change, so we empower our team to educate and advocate.
We’re eager to share stories that show why this work matters so much. We aim to meet skepticism with patience, and hostility with kindness.
We seek to transform how addiction is perceived, medicine is practiced, and care is delivered.
Innovation must be sweeping, dramatic, and fast. We’re charging forward defiantly – because we can’t afford not to.
It is rare to find a truly diverse startup team. We’re so proud to be building one.
We construct bridges across insular worlds of clinical care, community service, technology development, and academia: uniting extraordinary minds under shared goals.
Founder & Chief Executive Officer
Dr. Amanda Wilson, MD, MA, FASAM
Co-Founder & Investor
Mary Jean “MJ” Darby, RN
Founder & Chief Development Officer
Chief Technology Officer
Gregory Carroll, MD, MBA
Chief Operations Officer
Andy Mendenhall, MD
Advising Medical Director
Stephen Martin, MD, EdM
Medical Director, Head of Research, Education & Quality
Ginger Ross, CRSW, Psychology, US Army Veteran
Program Manager, Certified Peer Coaching
Brandon Lynch, MD, MPH
Nameeta Dookeran, MD, MS, FASAM, FACP
Consulting Staff Physician
Jordon Bosse, PhD, RN
Project Manager: Research and Education
Executive Assistant & Project Manager
Cheryl Cohen, LPC, CADC
Mark Shatsky, DO
Advising Chief Medical Informatics Officer
Director of Engineering
Alyson Smith, MD
Co-Founder and Partner, First Round Capital
Veteran healthcare and technology executive
Investor, Board Observer - Acumen America, Director
Andrey Ostrovsky, MD
Former Chief Medical Officer, US Medicaid
John D. Musil, PharmD, FACA
Founder & Chairman, Avella Specialty Pharmacy (the nation's largest independent specialty pharmacy, acquired by Optum)
Investor - BoxGroup, Partner
Healthcare Investor and Advisor